UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-K/A
Amendment No. 1
 
x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended December 31, 2018
 
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from _______ to ______
 
Commission File Number: 000-53089
 
Rafina Innovations Inc.
(Exact name of registrant as specified in its charter)
 
Nevada
 
30-0428006
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
Kintyre House, 209 Govan Road, Glasgow Scotland G51 1HJ
 (Address of principal executive office)
 
Registrant's telephone number, including area code: +44 141 370 0321
 
Securities registered pursuant to Section 12(b) of the Act:
None
 
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.0001 par value
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No
 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No 
 
Indicate by check mark whether the registrant has submitted electronically on its corporate Web site, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
 
 
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
 
 
Emerging growth company   
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes     No 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No
 
The aggregate market value of voting and non-voting common stock held by non-affiliates of the registrant as at June 29, 2018 (the last business day of the registrant's most recently completed second quarter), was approximately $4,903,852 based on the $2.00 per share which was the last selling price of the Company's common stock, assuming solely for the purpose of this calculation that all directors, officers and greater than 10% stockholders of the registrant are affiliates. The determination of affiliate status for this purpose is not necessarily conclusive for any other purpose. 

APPLICABLE ONLY TO CORPORATE REGISTRANTS

Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date.
 
 
15,719,681 shares of common stock issued and outstanding as of May 15, 2019
 

DOCUMENTS INCORPORATED BY REFERENCE

List hereunder the following documents if incorporated by reference and the Part of the Form 10-K (e.g. Part I, Part II, etc.) into which the document is incorporated: (1) Any annual report to security holders; (2) Any proxy or information statement; and (3) Any prospectus filed pursuant to Rule 424(b) or (c) of the Securities Act of 1933. The listed documents should be clearly described for identification purposes.
 
 
None
 
2

EXPLANATORY NOTE
 
This Amendment No. 1 on Form 10-K/A (this "Amendment") of Rafina Innovations Inc. for the fiscal year ended December 31, 2018 is being filed for the sole purpose of furnishing Exhibit 101 to the Form 10-K in accordance with Rule 405 of Regulation S-T.
 
This Amendment to the Form 10-K speaks as of the original filing date of the Form 10-K (the "Filing Date"), does not reflect events which may have occured subseqeuent to the Filing Date, and other than as set out above, does not modify or update in any way disclosures included in the original Form 10-K as filed on May 16, 2019.
 
 
 
 
 
3

TABLE OF CONTENTS

 
 
Page
 
PART I
 
 
 
 
Item 1
Business
 2
Item 1A
Risk Factors
 24
Item 1B
Unresolved Unresolved Staff Comments
 24
Item 2
Properties
 24
Item 3
Legal Proceedings
 25
Item 4
Mine Safety Disclosures
 25
 
 
 
 
PART II
 
 
 
 
Item 5
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
 26
Item 6
Selected Financial Data
 27
Item 7
Management's Discussion and Analysis of Financial Condition and Results of Operations
 27
Item 7A
Quantitative and Qualitative Disclosures About Market Risk
 30
Item 8
Financial Statements and Supplementary Data
 F-1
 
 
 
Item 9
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
 31
Item 9A
Controls and Procedures
 31
Item 9B
Other Information
 32
 
 
 
 
PART III
 
 
 
 
Item 10
Directors, Executive Officers and Corporate Governance
 33
Item 11
Executive Compensation
 35
Item 12
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
 37
Item 13
Certain Relationships and Related Transactions, and Director Independence
 39
Item 14
Principal Accounting Fees and Services
 42
 
 
 
 
PART IV
 
 
 
 
Item 15
Exhibits, Financial Statement Schedules
 44
 
 
 
 
SIGNATURES
 45
 
4

 
PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
Exhibits:
Description
 
3.1.1
Articles of Incorporation
Incorporated by reference to our Registration Statement filed with the SEC on Form SB-2 dated June 29, 2007.
3.1.2
Certificate of Amendment to the Articles of Incorporation
Incorporated by reference to our Definitive 14C filed with the SEC on December 27, 2013
3.1.3
Certificate of Amendment to the Articles of Incorporation
Incorporated by reference to our Definitive 14C filed with the SEC on March 3, 2014
3.1.4
Certificate of Change to the Articles of Incorporation
Incorporated by reference to our Form 8-K filed with the SEC on August 7, 2015
3.2
Bylaws
Incorporated by reference to our Registration Statement filed with the SEC on Form SB-2/A dated October 11, 2007.
4.1
Certificate of Designation
Incorporated by reference to our Definitive 14C filed with the SEC on December 27, 2013
10.1
Acquisition Agreement between HCi VioCare Technologies Limited and Christos Kapatos dated February 2, 2014
Incorporated by reference to our Form 8-K filed with the SEC on February 14, 2014.
10.2
Acquisition Agreement between HCi VioCare Technologies Limited and Dr. Christos Kapatos dated April 16, 2014
Incorporated by reference to our Form 8-K filed with the SEC on May 6, 2014
10.3
Form of Advisory Board Agreement
Incorporated by reference to our Form 8-K filed with the SEC on May 6, 2014
10.4
The Amendment of Acquisition Agreement between HCi VioCare Technologies Limited and Dr. Christos Kapatos dated May 8, 2015
Incorporated by reference to our Form 8-K filed with the SEC on May 13, 2015
 
14.1
Code of Ethics
Incorporated by reference to the registration statement filed with the SEC on Form 10-K dated April 6, 2009.
21
List of subsidiaries
 
- HCi Viocare Clinics UK Limited
- HCi Viocare Technologies UK Limited
 
31.1
Certification of Principal Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Filed herewith
31.2 Certification of Principal Financial Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Filed herewith
32.1
Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Filed herewith
101.CAL
XBRL Taxonomy Extension Calculation Linkbase
Filed herewith
101.DEF
XBRL Taxonomy Extension Definition Linkbase
Filed herewith
101.INS
XBRL Instance Document
Filed herewith
101.LAB
XBRL Taxonomy Extension Label Linkbase
Filed herewith
101.PRE
XBRL Taxonomy Extension Presentation Linkbase
Filed herewith
101.SCH
XBRL Taxonomy Extension Schema
Filed herewith
 

5


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 
Rafina Innovations Inc.
 
 
 
 
Date:
May 20, 2019
By:
/s/ Constantinos Zertalis
 
 
Name:
Constantinos Zertalis
 
 
Title:
Chief Executive Officer and President (Principal Executive Officer)
 
 
 
 
Date:
May 20, 2019
By:
/s/ P araskevi Pylarinou
 
 
Name:
Paraskevi Pylarinou
 
 
Title:
Director, Secretary and CFO (Principal Financial Officer and Principal Accounting Officer)
       
       
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Date:
May 20, 2019
By:
/s/ Constantinos Zertalis
 
 
Name:
Constantinos Zertalis
 
 
Title:
President, Chief Executive Officer, Chief Financial Officer, and Director (Principal Executive Officer))
 
 
 
 
Date:
May 20, 2019
By:
/s/ P araskevi Pylarinou
 
 
Name:
Paraskevi Pylarinou
 
 
Title:
Director, Secretary and CFO (Principal Financial Officer and Principal Accounting Officer)
 
 
 
 
Date:
May 20, 2019
By:
/s/ Yiannis Levantis
 
 
Name:
Yiannis Levantis
 
 
Title:
Director
 
 
 
 
Date:
May 20, 2019
By:
/s/Georgios Thrapsaniotis
 
 
Name:
Georgios Thrapsaniotis
 
 
Title:
Director and Treasurer
 
 
 
 
 
 
 
 


 

6
Rafina Innovations (CE) (USOTC:VICA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Rafina Innovations (CE) Charts.
Rafina Innovations (CE) (USOTC:VICA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Rafina Innovations (CE) Charts.